Ludwig San Diego’s Don Cleveland and Ludwig Harvard Co-director George Demetri were named Fellows of the Academy of the American Association for Cancer Research (AACR) in April. Election to the Academy, the AACR notes, recognizes and honors “distinguished scientists whose scientific contributions have propelled significant innovation and progress against cancer.” Nominees are elected through an annual peer review process conducted by existing members of the AACR Academy and ratified by the AACR Academy Steering Committee and AACR Executive Committee. The Academy recognized Don for his discovery and development of antisense oligonucleotide therapy, and his extensive contributions to our understanding of the molecular biology of cell division, chromosome movement and the mechanisms of genome evolution in cancer. George was honored for his landmark contributions to the development of targeted drugs and personalized cancer care regimens for sarcomas.
This article appeared in the August 2021 issue of Ludwig Link. Click here to download a PDF (2MB)